chloroquine retinopathy form toxic retinopathy damage retina caused drugs chloroquine hydroxychloroquine sometimes used treatment autoimmune disorders rheumatoid arthritis systemic lupus erythematosus eye toxicity limits longterm use risk toxicity low individuals without complicating conditions first five years treatment using less mgkgday hydroxychloroquine mgkgday chloroquine andor cumulative doses less gram gram total dose respectively physicians suggest lean body weight accurate calculating daily patients routinely given mg hydroxychloroquine daily mg chloroquine dose considered earliest signs toxicity include bilateral paracentral visual field changes best detected red test object subtle granular depigmentation paracentral rpe continued drug exposure progressive development bilateral atrophic bullseye maculopathy paracentral scotomata may severe cases ultimately spread entire fundus causing widespread retinal atrophy visual loss agents bind melanin pigment rpe may serve concentrate drugs prolong adverse effects patients primary care physicians must made fully aware ophthalmic risks need regular screening examinations detect retinal toxicity early stage baseline evaluation patients beginning treatment chloroquine derivative include complete eye examination eye care professional retinal photography followup comparisons visual field testing white pattern central visual field assessment test central vision white test target humphrey program patients risk unclear presentation optical coherence tomography loss isos junctions fundus autofluorescence focal hyper hypoautofluorescence multifocal electroretinography paracentral depressions may obtained profound abnormalities detected visual field multifocal electroretinography testing observed presence normal retinal appearance retinal examinations advised documentation visible bullseye maculopathy late goal screening recognize toxicity earlier stage annual screening begin years sooner unusual risk cessation drug first sign toxicity recommended treatment exists yet disorder imperative patients ophthalmologists aware best practices minimizing toxic damage associated visual loss rarely recovers may even progress drug discontinued httpsenwikipediaorgwikichloroquineretinopathy